Gyre Therapeutics Earnings
NASDAQ: GYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Fri, Nov 6, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.14
Gyre Therapeutics earnings summary
Gyre Therapeutics is scheduled to report Sep/2026 earnings on Nov 6, 2026, with analysts expecting EPS of $-0.14. In its most recent report on Aug 7, 2026 (Q2 2026), GYRE posted EPS of $-0.12. Revenue for the quarter was $29.1 million.
Across the last 16 reports, GYRE shares moved an average of 8.8% (in either direction) in the first trading session after results, rising 6 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
GYRE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 7, 2026 | — | $-0.12 | — | +0.1% |
| May 8, 2026 | — | $-0.10 | — | -12.3% |
| Mar 13, 2026 | — | $0.02 | — | -11.1% |
| Nov 7, 2025 | — | $0.03 | — | +10.8% |
| Aug 11, 2025 | — | $-0.03 | — | +0.5% |
| May 9, 2025 | — | $0.00 | — | +19.1% |
| Mar 17, 2025 | — | $0.00 | — | -6.2% |
| Nov 13, 2024 | — | $0.01 | — | -13.9% |
| Aug 13, 2024 | — | $0.01 | — | +17.9% |
| May 13, 2024 | — | $0.03 | — | -15.8% |
| Mar 27, 2024 | — | $-1.51 | — | -3.0% |
| Oct 26, 2023 | — | $0.05 | — | -18.7% |
| Aug 14, 2023 | — | $0.02 | — | +9.3% |
| May 15, 2023 | — | $0.03 | — | 0.0% |
| Mar 30, 2023 | — | $-0.99 | — | 0.0% |
| Nov 14, 2022 | — | $-0.16 | — | -1.8% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.